Patents by Inventor Steven Charles Reitz

Steven Charles Reitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease
    Patent number: 7067515
    Abstract: The invention provides compounds of Formula I: where in W is These compounds may be in the form of pharmaceutical salts or compositions, racemic mixtures, or pure enantiomers thereof. The compounds of Formula I are useful to treat diseases or conditions in which ?7 is known to be involved.
    Type: Grant
    Filed: June 6, 2002
    Date of Patent: June 27, 2006
    Assignee: Pfizer Inc.
    Inventors: Donn G. Wishka, Steven Charles Reitz, David W. Piotrowski, Vincent E. Groppi, Jr.
  • Azabicyclic compounds for the treatment of disease
    Patent number: 7001900
    Abstract: The invention provides compounds of Formula I: wherein Azabicyclo is W is a six-membered heterocyclic ring system having 1–2 nitrogen atoms or a 10-membered bicyclic-six-six-fused-ring system having up to two nitrogen atoms within either or both rings, provided that no nitrogen is at a bridge of the bicyclic-six-six-fused-ring system, and further having 1–2 substitutents independently selected from R3. These compounds may be in the form of pharmaceutical salts or compositions, may be in pure enantiomeric form or racemic mixtures, and are useful in pharmaceuticals to treat diseases or conditions in which ?7 is known to be involved.
    Type: Grant
    Filed: February 14, 2003
    Date of Patent: February 21, 2006
    Assignee: Pfizer Inc.
    Inventors: Eric Jon Jacobsen, Jason K. Myers, Daniel Patrick Walker, Donn G. Wishka, Steven Charles Reitz, David W. Piotrowski, Brad A. Acker, Vincent E. Groppi, Jr.
  • Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
    Patent number: 6911543
    Abstract: The invention provides compounds of Formula I: wherein Azabicyclo is These compounds may be in the form of pharmaceutical salts or compositions, racemic mixtures, or pure enantiomers thereof. The compounds of Formula I are useful in pharmaceuticals in which ?7 is known to be involved.
    Type: Grant
    Filed: October 1, 2002
    Date of Patent: June 28, 2005
    Assignee: Pfizer Inc.
    Inventors: Daniel Patrick Walker, David W. Piotrowski, Eric Jon Jacobsen, Brad A. Acker, Donn G. Wishka, Steven Charles Reitz
  • Azabicyclic compounds for the treatment of disease
    Publication number: 20030236270
    Abstract: The invention provides compounds of Formula I: 1
    Type: Application
    Filed: February 14, 2003
    Publication date: December 25, 2003
    Inventors: Eric Jon Jacobsen, Jason K. Myers, Daniel Patrick Walker, Donn G. Wishka, Steven Charles Reitz, David W. Piotrowski, Brad A. Acker, Vincent E. Groppi
  • Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
    Publication number: 20030153595
    Abstract: The invention provides compounds of Formula I: 1
    Type: Application
    Filed: October 1, 2002
    Publication date: August 14, 2003
    Inventors: Daniel Patrick Walker, David W. Piotrowski, Eric Jon Jacobsen, Brad A. Acker, Donn G. Wishka, Steven Charles Reitz, Vincent E. Groppi
  • Substituted 7-aza[2.2.1]bicycloheptanes for the treatment of disease
    Publication number: 20030105089
    Abstract: The invention provides compounds of Formula I: 1
    Type: Application
    Filed: September 4, 2002
    Publication date: June 5, 2003
    Inventors: Donn G. Wishka, Daniel Patrick Walker, Jeffrey W. Corbett, Steven Charles Reitz, Mark R. Rauckhorst, Vincent E. Groppi
  • Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease
    Publication number: 20030045540
    Abstract: The invention provides compounds of Formula I: 1
    Type: Application
    Filed: June 6, 2002
    Publication date: March 6, 2003
    Inventors: Donn G. Wishka, Steven Charles Reitz, David W. Piotrowski, Vincent E. Groppi